# ProPhase Labs Inc. (PRPH)

Source: https://www.quantisnow.com/company/PRPH
Generated: 2026-11-08T08:36:08.213Z

- Ticker: PRPH
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- SEC CIK: 0000868278
- Website: prophaselabs.com

## About

ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter (OTC) consumer healthcare products and dietary supplements in the United States. It offers a range of OTC dietary supplements, including Legendz XL for sexual health; Triple Edge XL, an energy booster and testosterone support product; and Super ProstaFlow+ a supplement to support prostate and urinary health under the TK Supplements brand. The company also provides contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; and offers SARS-CoV-2 (COVID-19) and COVID-19 viral mutation PCR tests through saliva and nasal swab methods, as well as other respiratory pathogen panel testing services, including Influenza A and B, and others. It serves consumer products companies, as well as large national chain, regional, specialty, and local retail stores. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was incorporated in 1989 and is headquartered in Garden City, New York.

## Latest PRPH news and filings

- 2026-08-19 20:31 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by ProPhase Labs Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-prophase-labs-inc-6688556)
- 2026-08-14 20:30 UTC [SEC Form NT 10-Q filed by ProPhase Labs Inc.](https://www.quantisnow.com/insight/sec-form-nt-10-q-filed-by-prophase-labs-inc-6683198)
- 2026-08-06 21:00 UTC [SEC Form 8-K] [ProPhase Labs Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits](https://www.quantisnow.com/insight/prophase-labs-inc-filed-sec-form-8-k-entry-into-a-6669874)
- 2026-07-09 19:12 UTC [SEC Form 10-Q] [Amendment: SEC Form 10-Q/A filed by ProPhase Labs Inc.](https://www.quantisnow.com/insight/amendment-sec-form-10-qa-filed-by-prophase-labs-inc-6632865)
- 2026-07-07 13:23 UTC [SEC Form 10-Q] [Amendment: SEC Form 10-Q/A filed by ProPhase Labs Inc.](https://www.quantisnow.com/insight/amendment-sec-form-10-qa-filed-by-prophase-labs-inc-6629774)
- 2026-06-30 20:50 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by ProPhase Labs Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-prophase-labs-inc-6621129)
- 2026-06-01 21:13 UTC [SEC Form 10-K] [SEC Form 10-K filed by ProPhase Labs Inc.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-prophase-labs-inc-6582371)
- 2026-05-15 20:30 UTC [SEC Form NT 10-Q filed by ProPhase Labs Inc.](https://www.quantisnow.com/insight/sec-form-nt-10-q-filed-by-prophase-labs-inc-6557874)
- 2026-04-15 13:05 UTC [Public Offering] [ProPhase Labs Reports Year-End 2025 Results, Highlights Accelerating Settlement Activity and Investment-Ready Crown Medical Collections Platform](https://www.quantisnow.com/insight/prophase-labs-reports-year-end-2025-results-highlights-accelerating-settlement-activity-6500765)
- 2026-03-27 21:10 UTC [SEC Form NT 10-K filed by ProPhase Labs Inc.](https://www.quantisnow.com/insight/sec-form-nt-10-k-filed-by-prophase-labs-inc-6475139)
- 2026-03-17 12:00 UTC [ProPhase Labs Provides Business Update Highlighting Advancing Crown Medical Collections Activity](https://www.quantisnow.com/insight/prophase-labs-provides-business-update-highlighting-advancing-crown-medical-collections-6451192)
- 2026-02-13 22:15 UTC [SEC Form 8-K] [ProPhase Labs Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/prophase-labs-inc-filed-sec-form-8-k-other-events-financial-6393175)
- 2026-02-13 22:15 UTC [SEC Form 8-K] [ProPhase Labs Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/prophase-labs-inc-filed-sec-form-8-k-other-events-financial-6393173)
- 2026-02-03 12:00 UTC [ProPhase Labs Initiates Potential Sale or Strategic Partnership of BE-Smart™ and Advances Crown Medical Collections Initiative](https://www.quantisnow.com/insight/prophase-labs-initiates-potential-sale-or-strategic-partnership-of-be-smart-6371150)
- 2026-02-02 13:00 UTC [Conference Announcement] [Join ProPhase Labs' Exclusive Live Investor Webinar and Q&A Session on February 3rd](https://www.quantisnow.com/insight/join-prophase-labs-exclusive-live-investor-webinar-and-qa-session-6369055)
- 2026-01-27 16:06 UTC [SEC Form 8-K] [ProPhase Labs Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/prophase-labs-inc-filed-sec-form-8-k-other-events-financial-6361925)
- 2026-01-26 12:00 UTC [ProPhase Labs Provides Crown Medical Collections Update; 250+ Insurance Payors Engaged, Approximately 50 Matters in Advanced Settlement Posture](https://www.quantisnow.com/insight/prophase-labs-provides-crown-medical-collections-update-250-insurance-payors-6359980)
- 2026-01-23 22:20 UTC [SEC Form 8-K] [ProPhase Labs Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/prophase-labs-inc-filed-sec-form-8-k-other-events-financial-6359614)
- 2026-01-23 22:15 UTC [SEC Form 8-K] [ProPhase Labs Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits](https://www.quantisnow.com/insight/prophase-labs-inc-filed-sec-form-8-k-entry-into-a-6359595)
- 2026-01-22 12:00 UTC [ProPhase Labs Uplists from Pink Sheets to OTC Market](https://www.quantisnow.com/insight/prophase-labs-uplists-from-pink-sheets-to-otc-market-6356971)
- 2026-01-09 22:15 UTC [SEC Form 8-K] [ProPhase Labs Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/prophase-labs-inc-filed-sec-form-8-k-other-events-financial-6344771)
- 2026-01-09 22:10 UTC [SEC Form 8-K] [ProPhase Labs Inc. filed SEC Form 8-K: Leadership Update](https://www.quantisnow.com/insight/prophase-labs-inc-filed-sec-form-8-k-leadership-update-6344741)
- 2026-01-05 10:00 UTC [ProPhase Labs Provides Update on Convertible Debt Conversions, Capital Structure, and Underlying Asset Value](https://www.quantisnow.com/insight/prophase-labs-provides-update-on-convertible-debt-conversions-capital-structure-6332873)
- 2026-01-02 22:10 UTC [SEC Form 8-K] [ProPhase Labs Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits](https://www.quantisnow.com/insight/prophase-labs-inc-filed-sec-form-8-k-notice-of-delisting-6332565)
- 2025-12-29 22:04 UTC [SEC Form 424B5] [SEC Form 424B5 filed by ProPhase Labs Inc.](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-prophase-labs-inc-6328889)
- 2025-12-19 20:37 UTC [SEC Form 8-K] [ProPhase Labs Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/prophase-labs-inc-filed-sec-form-8-k-other-events-financial-6323543)
- 2025-12-19 18:07 UTC [SEC Form 8-K] [ProPhase Labs Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/prophase-labs-inc-filed-sec-form-8-k-other-events-financial-6323455)
- 2025-12-19 18:03 UTC [SEC Form 424B5] [SEC Form 424B5 filed by ProPhase Labs Inc.](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-prophase-labs-inc-6323452)
- 2025-12-19 14:48 UTC [Dividends] [From Super Fibers to Super Deals: Science, Scale, and Strategic Capital Shape the Morning Tape](https://www.quantisnow.com/insight/from-super-fibers-to-super-deals-science-scale-and-strategic-6323322)
- 2025-12-19 12:00 UTC [Earnings Date] [ProPhase Labs Signs Non-Binding LOI for Proposed Reverse Merger with Advanced Biological Laboratories](https://www.quantisnow.com/insight/prophase-labs-signs-non-binding-loi-for-proposed-reverse-merger-with-6323037)
- 2025-12-18 18:30 UTC [SEC Form 8-K] [Amendment: ProPhase Labs Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/amendment-prophase-labs-inc-filed-sec-form-8-k-amendments-to-6321796)
- 2025-12-12 16:41 UTC [SEC Form 8-K] [Amendment: ProPhase Labs Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/amendment-prophase-labs-inc-filed-sec-form-8-k-amendments-to-6313703)
- 2025-11-26 19:15 UTC [SEC Form 8-K] [ProPhase Labs Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits](https://www.quantisnow.com/insight/prophase-labs-inc-filed-sec-form-8-k-submission-of-matters-6294871)
- 2025-11-26 13:00 UTC [Conference Announcement] [Join ProPhase Labs' Exclusive Live Investor Webinar and Q&A Session on December 1](https://www.quantisnow.com/insight/join-prophase-labs-exclusive-live-investor-webinar-and-qa-session-6294507)
- 2025-11-25 21:30 UTC [SEC Form 8-K] [ProPhase Labs Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/prophase-labs-inc-filed-sec-form-8-k-entry-into-a-6293817)
- 2025-11-25 21:30 UTC [SEC Form 8-K] [ProPhase Labs Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/prophase-labs-inc-filed-sec-form-8-k-other-events-financial-6293816)
- 2025-11-19 21:06 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by ProPhase Labs Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-prophase-labs-inc-6286908)
- 2025-11-19 14:00 UTC [SEC Form 8-K] [ProPhase Labs Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/prophase-labs-inc-filed-sec-form-8-k-results-of-operations-6286468)
- 2025-11-19 13:13 UTC [Earnings Date] [ProPhase Labs Reported Results for the Third Quarter Ended September 30, 2025, and Will Hold a Virtual Conference Call Today at 2pm ET.](https://www.quantisnow.com/insight/prophase-labs-reported-results-for-the-third-quarter-ended-september-6286286)
- 2025-11-18 13:00 UTC [Earnings Date] [ProPhase Labs, Inc. to Present Third Quarter 2025 Financial Results on November 19](https://www.quantisnow.com/insight/prophase-labs-inc-to-present-third-quarter-2025-financial-results-6284029)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/PRPH
- Earnings history: https://www.quantisnow.com/earnings/PRPH
- Dividend history: https://www.quantisnow.com/dividends/PRPH
- Insider transactions: https://www.quantisnow.com/insiders/PRPH
- Options chain: https://www.quantisnow.com/options/PRPH
- SEC 8-K filings only: https://www.quantisnow.com/company/PRPH/8-k
- RSS and alerts for PRPH: https://www.quantisnow.com/docs/rss-feeds.md